Skip to main content
SpringerLink
Log in

Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor)

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

The subjects in this study consisted of 40 preoperative untreated esophageal squamous cell carcinoma patients. While p53 did not significantly correlate with the clinicopathological factors, E-cadherin significantly correlated with lymphatic invasion, vascular invasion, the depth of invasion, the degree of lymph node metastasis, the histological stage, and the number of lymph node metastases. Epidermal growth factor receptor (EGFR) significantly correlated with age, the depth of invasion, and the number of lymph node metastases. The 5-year cumulative survival rate was 45.7% in the p53-positive cases and 61.9% in the p53-negative cases, with no significant difference, and 87.8% in the E-cadherinpositive cases and 19.1% in the-negative cases, and the difference was significnat. The prognosis was significantly poor in EGFR-positive subjects: the 5-year survival rate was 38.6% in EGFR-positive cases and 68% in-negative cases. The 5-year survival rate in E-cadherin-negative, EGFR-positive cases was 0%, while it was 91.7% in the reverse pattern, and this difference was significant. These findings suggest that both E-cadherin and EGFR are important prognostic factors, and a more precise prognosis can thus be obtained by combining them. Such a combined technique may be very useful as an indicator for grading the biological malignancy of esophageal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Muroi M (1995) A clinicopathological study on extensive lymph node dissection for thoracic esophageal cancer (in Japanese with English abstract). Nippon Kyobu Geka Gakkai Zasshi (J Jpn Assoc Thorac Surg) 43:287–299

    CAS  PubMed  Google Scholar 

  2. Kakegawa T, Yamana H (1995) Progress in surgical treatment of carcinoma of the intrathoracic esophagus (in Japanese with English abstract). Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 22:855–862

    CAS  PubMed  Google Scholar 

  3. Kotoh T, Arima S, Inada S, Futami K (1995) A study of lymph node metastasis and recurrence in thoracic esophageal cancer. Med Bull Fukuoka Univ 22:53–60

    Google Scholar 

  4. Japanese Society for Esophageal Disease (1992) Guidelines for the clinical and pathological studies on carcinoma of the esophagus, 8th edn. Kinahara, Tokyo

    Google Scholar 

  5. Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 34:187–220

    Google Scholar 

  6. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705–708

    Article  CAS  PubMed  Google Scholar 

  7. Wagata T, Ishizaki K, Imamura M, Shimada Y, Ikenaga M, Tobe T (1991) Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. Cancer Res 51:2113–2117

    CAS  PubMed  Google Scholar 

  8. Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC (1990) Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 87:9958–9961

    Article  CAS  PubMed  Google Scholar 

  9. Hollstein MC, Peri L, Mandard AM, Welsh JA, Montesano R, Metcalf RA, Bak M, Harris CC (1991) Genetic analysis of human esophageal tumors from two high-incidence geographic areas: frequent p53 base substitutions and absence of ras mutation. Cancer Res 51:4102–4106

    CAS  PubMed  Google Scholar 

  10. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half-life. Mol Cell Biol 8:531–539

    CAS  PubMed  Google Scholar 

  11. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE (1994) p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74:2218–2223

    Article  CAS  PubMed  Google Scholar 

  12. Goukon Y, Sasano H, Nishihira T, Nagura H, Mori S (1994) p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study. Anticancer Res 14:1305–1312

    CAS  PubMed  Google Scholar 

  13. Shimaya K, Shinozaki H, Inoue M, Tahara H, Monden T, Shimano T, Mori T (1993) Significance of p53 expression as a prognostic factor in esophageal squamous cell carcinoma. Virchows Arch (A) 422:271–276

    Article  CAS  Google Scholar 

  14. Shiozaki H, Miyata M, Kobayashi K, Tahara H, Tamura S, Yano H, Oka H, Doki Y, Iihara K, Mori T, Hirano S, Takeichi M (1991) Correlation between E-cadherin expression and lymphnode metastasis in esophageal cancer (in Japanese with English abstract). Nippon Syoukakigeka Gakkai Zassi (Jpn J Gastroenterol Surg) 24:1117–1120

    Google Scholar 

  15. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, Iihara K, Matsui S, Iwazawa T, Nagafuchi A, Tsukita S, Mori T (1994) E-cadherin and α catenin expression in human esophageal cancer. Cancer Res 54:291–296

    CAS  PubMed  Google Scholar 

  16. Cohen S, Ushio H, Stoscheck C, Chinkers M (1982) A native 170 000 epidermal growth factor receptor kinase complex from shed plasma membrane vesicle. J Biol Chem 257:1523–1531

    CAS  PubMed  Google Scholar 

  17. Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gamou S, Shimizu N (1986) High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 46:414–416

    CAS  PubMed  Google Scholar 

  18. Lewis S, Locker A, Todd JH, Bell JA, Nicholson R, Elston CW, Blamey RW, Ellis IO (1990) Expression of epidermal growth factor receptor in breast carcinoma. J Clin Pathol 43:385–389

    Article  CAS  PubMed  Google Scholar 

  19. Yonemura Y, Sugimati K, Kamata T, Fushida S, Yamaguchi A, Miwa K, Miyazaki I (1988) Correlation of epidermal growth factor receptor status and clinical outcome in gastric carcinoma (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 89:1611–1615

    CAS  PubMed  Google Scholar 

  20. Arai M, Hirose K, Nakagawara G, Inuzuka M (1994) Expression of human epidermal growth factor and its receptor of the gastric carcinomas with special reference to DNA ploidy patterns and nucleolar organizer regions (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 95:171–178

    CAS  PubMed  Google Scholar 

  21. Yano H, Shiozaki H, Kobayashi K, Yano T, Tahara H, Tamura S, Mori T (1991) Immunohistologic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma. Cancer 67:91–98

    Article  CAS  PubMed  Google Scholar 

  22. Itakura Y, Sasano H, Shiga C, Shiga K, Nishihira T, Nagura H, Mori S (1993) Immunohistochemical analysis of epidermal growth factor receptor (EGFR) overexpression in esophageal carcinoma (in Japanese with English abstract). Shokakigan No Hassei To Shinten (J Jpn Res Gastroenterol Carcinogen) 5:195–199

    Google Scholar 

  23. Fukuda M, Okamura K, Fujita S, Böhm N, Rohrbach R, Sandritter W (1978) The different stem cell populations in mouse epidermis and lingual epithelium, Pathol Res Pract 163:205–227

    CAS  PubMed  Google Scholar 

  24. Fukuyama R, Shimizu N (1991) Detection of epidermal growth factor receptors and E-cadherin in the basolateral membrane of A431 cells by laser scanning florescence microscopy. Jpn J Cancer Res 82:8–11

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan

    Shigemitsu Inada, Tsuyoshi Koto, Kitaro Futami & Sumitaka Arima

  2. Department of Pathology, Chikushi Hospital, School of Medicine, Fukuoka University, 377-1 Zokumyoin, 818-8502, Chikushino-shi, Fukuoka, Japan

    Shigemitsu Inada & Akinori Iwashita

Authors
  1. Shigemitsu Inada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tsuyoshi Koto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kitaro Futami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sumitaka Arima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akinori Iwashita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inada, S., Koto, T., Futami, K. et al. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). Surg Today 29, 493–503 (1999). https://doi.org/10.1007/BF02482343

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02482343

Key Words

Search

Navigation